Rousselot receives 2009 Frost & Sullivan Growth Strategy Excellence Award for its success within the European bone and joint health ingredients market

Puteaux, September 22 2009 – Rousselot, the world’s leading producer of gelatine and hydrolyzed collagen has received the “2009 Frost & Sullivan Growth Strategy Excellence Award” in the European bone and joint health ingredients market. Over the past few months, Rousselot has demonstrated its ability to promote the nutritional and bioactive qualities of its Peptan™ offer and successfully improved its positioning on the market thanks to a dynamic strategy of growth and external acquisition.

“We are most honoured by this award which acknowledges our efforts to efficiently meet the needs and very high expectations of the European bone and joint health market” said Laurent Weber, Rousselot Marketing & Sales Vice-President. We thought it important to develop a versatile, effective and proven range of products and to bring to our customers every support they need to develop new and innovative applications for health. We will continue to pursue our growth strategy and market approach and to provide our customers with the highest possible quality of products and services."

As the European population grows older, bone and joint health problems are on the increase. Studies demonstrate that 30 to 50 % of women and 20 % of men over the age of 50 are affected by osteoporosis (Source: International Osteoporosis Foundation) and that 18 % of women and 10 % of men suffer from arthritis (Source: World Health Organisation). Ingredients providing bone and joint-health benefits are therefore meeting with growing interest from health professionals and consumers.

With Peptan™ Hydrolyzed Collagen, Rousselot provides solid answers to these health issues. Scientific studies have reported that the oral ingestion of 10g of Hydrolyzed Collagen per day exerts a positive effect on health. The intake of Hydrolyzed Collagen leads to a significant increase in bone mass and a reduction in the number of fractures in osteoporosis sufferers (1) (2); Hydrolyzed Collagen also maintains joint health, and patients having the most severe arthritis symptoms benefit even more(3) (4).

Peptan™ has excellent organoleptic properties, and is available in a variety of molecular weights (2,000 to 5,000 Daltons) and densities. It is suitable for use in a range of application formats (capsules, powder blends, bars, functional drinks…).

The awards will be officially presented at the Growth Excellence Awards Banquet held in London on December 8th, 2009.

1. Moskowitz, R. (2000). "Role of collagen hydrolysate in bone and joint disease". Seminars in arthritis and rheumatism 30(2): 87-99.

2. Ruiz-Benito, P.; Camacho-Zambrano, M.M., Carrillo-Arcentales, J.N., Mestanza-Peralta, M.A., Vallejo-Flores, C.A., Vargas-Lopez, S.V., Villacis-Tamayo, R.A. and Zurita-Gavilanes, L.A. (2009). "A randomized controlled trial on the efficacy and safety of a food ingredient, collagen hydrolysate, for improving joint comfort". International journal of food science and nutrition 12: 1-15.

3. Nomura, Y.; Oohashi, K., Watanabe, M. and Kasugai (2005). "Increase in bone mineral density through oral administration of shark gelatine to ovariectomized rats". S Nutrition 21: 1120-1126.

4. Wu, J.; Fujioka, M., Sugimoto, K., Mu, G. and Ishimi, Y (2004). "Increase of effectiveness of oral administration of collagen peptide on bone metabolism in growing and mature rats". Bone and mineral metabolism 22: 547-553.